Evidence-based activism: Patients', users' and activists' groups in knowledge society

BioSocieties

Volumn 9, Issue 2, 2014, Pages 111-128

  Rabeharisoa, Vololona ^a   Moreira, Tiago ^b   Akrich, Madeleine ^a  

^a CENTRE DE SOCIOLOGIE DE L INNOVATION   (France)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

collective inquiry; evidence based activism; expertise; health care policies; patients' and health activists' groups; technological democracies

Indexed keywords

EID: 84901614221     PISSN: 17458552     EISSN: 17458560     Source Type: Journal    
DOI: 10.1057/biosoc.2014.2     Document Type: Review

References (53)

1. Allsop, J., Jones, K. and Baggott, R. (2004) Health consumer groups in the UK: A new social movement?. Sociology of Health and Illness 26(6): 737-756
2. Arksey, H. (1994) Expert and lay participation in the construction of medical knowledge. Sociology of Health & Illness 16(4): 448-468
3. Baggott, R., Allsop, J. and Jones, K. (2004) Speaking for Patients and Carers: Health Consumer Groups and the Policy Process. Basingstoke, UK: Palgrave Macmillan
4. Barbot, J. (2002) Les malades en mouvements: La médecine et la science a l'épreuve du sida. Paris: Balland
5. Barbot, J. (2006) How to build and 'active' patient?. The work of AIDS associations in France. Social Science & Medicine 62(3): 538-551
6. Barker, K.K. (2005) The Fibromyalgia Story: Medical Authority and Women's Worlds of Pain. Philadelphia, PA: Temple University Press
7. Barker, K.K. (2011) Listening to lyrica: Contested illnesses and pharmaceutical determinism. Social Science & Medicine 73(6): 833-842
8. Berg, M. and Mol, A. (eds.) (1998) Differences in Medicine. Unravelling Practices, Techniques and Bodies. Durham, NC: Duke University Press
9. Blume, S. (2009) The Artificial Ear: Cochlear Implants and the Culture of Deafness. New Brunswick, NJ: Rutgers University Press
10. Borkman, T. (1976) Experiential knowledge: A new concept for the analysis of self-help groups. The Social Service Review 50(3): 445-456
11. Brown, P. and Zavestoski, S. (2004) Social movements in health: An introduction. Sociology of Health&Illness 26(6): 679-694. (Pubitemid 39407085
12. Brown, P., Zavestoski, S.,McCormick, S.,Mayer, B.,Morello-Frosch, R. and Altman, R.G. (2004) Embodied health movements: New approaches to social movements in health. Sociology of Health & Illness 26(1): 50-80. (Pubitemid 38406170
13. Callon, M. (1986) Some elements of a sociology of translation: Domestication of the scallops and the fishermen of st Brieuc Bay. In: J. Law (ed.) Power, Action and Belief: A New Sociology of Knowledge. London: Routledge & Kegan Paul, pp. 196-223
14. Callon, M., Lascoumes, P. and Barthe, Y. (2009) Acting in an Uncertain World. An Essay on Technical Democracy. Cambridge, Massachusetts: MIT Press
15. Cambrosio, A., Keating, P., Schlich, T. and Weisz, G. (2006) Regulatory objectivity and the generation and management of evidence in medicine. Social Science & Medicine 63(1): 189-199. (Pubitemid 43668402
16. Clarke, A., Mamo, L., Fosket, J.R., Fishman, J.R. and Shim, J.K. (eds.) (2009) Biomedicalization: Technoscience, Health, and Illness in the US. Durham, NC: Duke University Press
17. Conrad, P. (1992) Medicalization and social control. Annual Review of Sociology 18: 209-232
18. Conrad, P. (2007) The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Baltimore, MD: John Hopkins University Press
19. Corbin, J. and Strauss, A. (1988) Unending Work and Care: Managing Chronic Illness at Home. San Francisco, CA: Jossey-Bass
20. Dodier, N. (2003) Leçons politiques de l'épidémie de sida. Paris: Editions de l'EHESS
21. Dodier, N. and Barbot, J. (2002) Multiplicity in scientific medicine: The experience of hiv-positive patients. Science, Technology & Human Value 27(3): 404-440
22. Epstein, S. (1995) The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Science, Technology, and Human Values 20(4): 408-437
23. Epstein, S. (1996) Impure Science: AIDS, Activism, and the Politics of Knowledge. Berkeley, CA: University of California Press
24. Epstein, S. (2007) Inclusion. The Politics of Difference in Medical Research. Chicago, IL: The University of Chicago Press
25. Epstein, S. (2008) Patient groups and health movements. In: E.J. Hackett, O. Amsterdamska, M. Lynch and J. Wajcman (eds.) The Handbook of Science and Technology Studies, 3rd edn. Massachusetts: MIT Press, pp. 499-538
26. Epstein, S. (2011) Measuring success: Scientific, institutional, and cultural effects of patient advocacy. In: B. Hoffman, N. Tomes, R. Grob and M. Schlesinger (eds.) Patients as Policy Actors. London: Rutgers University Press, pp. 257-277
27. Dumit, J. (2006) Illnesses you have to fight to get: Facts as forces in uncertain, emergent illnesses. Social Science & Medicine 62(3): 577-590
28. Frickel, S., Gibbon, S., Howard, J., Kempner, J., Ottinger, G. and Hess, D.J. (2010) Undone science: Charting social movement and civil society challenges to research agenda setting. Science, Technology and Human Values 35(4): 444-473
29. Haas, P.M. (1992) Introduction: Epistemic communities and international policy coordination. International Organization 46(1): 1-35
30. Hess, D.J. (2009) The potentials and limitations of civil society research: Getting undone science done. Sociological Inquiry 79(3): 306-327
31. Hoffman, B., Tomes, N., Grob, R. and Schlesinger, M. (eds.) (2011) Patients as Policy Actors. London: Rutgers University Press
32. Keating, P. and Cambrosio, A. (2003) Biomedical Platforms. Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge, MA: MIT Press
33. Landzelius, K. (2006) Introduction: Patient organization movements and new metamorphoses in patienthood. Social Science & Medicine 62(3): 529-537
34. Laurent, B. (2011) Technologies of democracy: Experiments and demonstrations. Science and Engineering Ethics 17(4): 649-666
35. Light, D.W. (1991) Professionalism as a countervailing power. Journal of Health Politics, Policy and Law 16(3): 499-506
36. Löfgren, H., de Leeuw, E. and Leahy, M. (eds.) (2011) Democratizing Health: Consumer Groups in the Policy Process. Cheltenham, UK: Edward Elgar
37. Mol, A. and Law, J. (1994) Regions, networks and fluids: Anaemia and social topology. Social Studies of Science 24: 641-671
38. Moreira, T. (2010) When trials are not enough: Clinical effectiveness versus cost-effectiveness in the dementia drugs controversy (2005-08). In: C. Will and T. Moreira (eds.) Medical Proofs, Social Experiments: Clinical Trials in Shifting Contexts. Farnam, UK: Ashgate, pp. 85-102
39. Moreira, T. (2012) Health care standards and the politics of singularities: Shifting in and out of context. Science, Technology & Human Values 37(4): 307-331
40. Novas, C. (2006) The political economy of hope: Disease advocacy organisations, science and biovalue. BioSocieties 1(3): 289-305
41. O'Donovan, O., Moreira, T. and Howlett, E. (2013) Tracking transformations in health movement organizations: Alzheimer's disease organizations and their changing cause regimes. Social Movement Studies 13(2): 316-334
42. Panofsky, A. (2011) Generating sociability to drive science: Patient advocacy organizations and genetics research. Social Studies of Science 41(1): 31-57
43. Pierret, J. (2003) The illness experience. State of knowledge and perspectives for research. Sociology of Health & Illness 25(3): 4-22
44. Rabeharisoa, V. and Callon, M. (1999) Le Pouvoir des malades. L'Association Française contre les Myopathies & la recherche. Paris: Les Presses de l'Ecole des mines de Paris
45. Rabeharisoa, V. and Callon, M. (2004) Patients and scientists in French muscular dystrophy research. In: S. Jasanoff (ed.) States of Knowledge. The Co-Production of Science and Social Order. London: Routledge, pp. 142-160
46. Rabeharisoa, V. (2006) From representation to mediation: The shaping of collective mobilization on muscular dystrophy in France. Social Science & Medicine 62(3): 564-576
47. Rabinow, P. (1999) Artificiality and enlightenment: From sociobiology to biosociality. In: M. Biagioli (ed.) The Science Studies Reader. New York and London: Routledge, pp. 407-416
48. Rapp, R., Heath, D. and Taussig, K-S. (2001) Genealogical dis-ease: Where hereditary abnormality, biomedical explanation, and family responsibility meet. In: F. Franklin and S. McKinnon (eds.) Relative Values: Reconfiguring Kinship Studies. Durham, NC: Duke University Press, pp. 384-409
49. Schicktanz, S. (2012) The troubles of representation: The legitimacy of PO as political actors. paper presented to the conference Patient Organizations, Health Movements and Medical Research: Varieties, Effects and Future of Civil Society Engagement in Science, Technology Development and Research Policies; 10-12 May, Augsburg
50. Silverman, C. (2011) Understanding Autism: Parents, Doctors, and the History of a Disorder. Princeton, NJ: Princeton University Press
51. Stengers, I. (2005) The cosmopolitical proposal. In: B. Latour and P. Weibel (eds.) Making Things Public: Atmospheres of Democracy. Cambridge, MA: MIT Press
52. Stockdale, A. (1997) Conflicting Perspectives. Coping with Cystic Fibrosis in the Age of Molecular Medicine. Brandeis University
53. Timmermans, S. and Berg, M. (2003) The Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care. Philadelphia, PA: Temple University Press